An individual requested the person requested the Federal Commission for the Protection of Health Risks (Cofepris) to provide the document in which the biopharmaceutical company which produced the vaccine stated that a second shot is required after 6 months from the first shot.

After not having received any reply within the deadline, the claimant seized the National Institute for Transparency, Access to Information and Personal Data Protection (INAI), requesting Cofepris to disclose the documentation. Before the INAI, Cofepris submitted that it could not disclose the document because it entails information related to national security which constitutes part of the National Strategy Plan.

On 6 March 2022, the INAI found that the requested clinical trials do not reveal any procedures, methods or technical specifications that could affect intelligence, national security, or strategic decisions with regards to the pandemic.

News available at es